Skip to main content

Home/ MaRS/ Group items tagged marketing

Rss Feed Group items tagged

Assunta Krehl

MobileMonday Toronto Launches Mobile Marketing Awards Competition September 8th - Marke... - 0 views

  • On September 8th, MobileMonday Toronto, Toronto's premier networking event for mobile industry professionals, will be hosting its first annual MobileMonday Toronto Marketing Awards. This event was set up to recognize Toronto area marketing professionals for their effort in helping grow the use of mobile as a marketing channel.
  • Since announcing the partnership with MaRS in February 2009, MobileMonday Toronto has experienced explosive growth with monthly attendance exceeding 250+ attendees and has received general appreciation for the chapter's approach to support all stakeholders within the mobile industry which includes telecom providers, device manufacturers, startups, venture capital and developers in addition to many industry verticals such as search, m-commerce, advertising, and media.
  • The first annual MobileMonday Toronto Marketing Awards will be held on Tuesday September 8th (due to Labour Day holiday) at MaRS Discovery District, located at 101 College Street (south east corner of College and University). The event starts at 6:30pm. To RSVP for this event, please visit www.mobilemondaytoronto.com.
  •  
    The first first annual MobileMonday Toronto Marketing Awards will be held September 8, 2009 at the MaRS Centre. MobileMonday is a partner of MaRS. MobileMonday Toronto Marketing Awards recognizse Toronto area marketing professionals for their effort in helping grow the use of mobile as a marketing channel. Sept 2, 2009
  •  
    The first first annual MobileMonday Toronto Marketing Awards will be held September 8, 2009 at the MaRS Centre. MobileMonday is a partner of MaRS. MobileMonday Toronto Marketing Awards recognizes Toronto area marketing professionals for their effort in helping grow the use of mobile as a marketing channel. Sept 2, 2009
Assunta Krehl

MobileMonday Celebrates Tuesday with Awards Gala - eSource Canada Business News Network - 0 views

  • MobileMonday Toronto, Toronto's premier networking event for mobile industry professionals, will be hosting its first annual MobileMonday Toronto Marketing Awards on Tuesday, September 8th, 2009The event recognizes Toronto area marketing professionals for their effort in helping grow the use of mobile as a marketing channel.
  • Since announcing the partnership with MaRS in February 2009, MobileMonday Toronto has experienced explosive growth with monthly attendance exceeding 250+ attendees and has received general appreciation for the chapter's approach to support all stakeholders within the mobile industry which includes telecom providers, device manufacturers, startups, venture capital and developers in addition to many industry verticals such as search, m-commerce, advertising, and media.
  • The first annual MobileMonday Toronto Marketing Awards will be held on Tuesday September 8th (due to Labour Day holiday) at MaRS Discovery District, located at 101 College Street (south east corner of College and University). The event starts at 6:30pm.
  •  
    The first first annual MobileMonday Toronto Marketing Awards will be held September 8, 2009 at the MaRS Centre. MobileMonday is a partner of MaRS. MobileMonday Toronto Marketing Awards recognizes Toronto area marketing professionals for their effort in helping grow the use of mobile as a marketing channel.
  •  
    The first first annual MobileMonday Toronto Marketing Awards will be held September 8, 2009 at the MaRS Centre. MobileMonday is a partner of MaRS. MobileMonday Toronto Marketing Awards recognizes Toronto area marketing professionals for their effort in helping grow the use of mobile as a marketing channel. Sept 5, 2009
Sarah Hickman

MaRS Discovery District - Recommended Resources - Global Market Reports - Private Equit... - 0 views

  •  
    An in-depth review of the private equity market in Canada. This fifth installment in the series, produced in conjunction with McKinsey & Company, provides a fact-based perspective of the key trends shaping the Canadian private equity market Volume 1: produced by Goodman and Carr LLP, provides an in-depth review of key market facts. It describes the main characteristics of Canada's private equity market, the preferences of its participants, and the market activity over the past year.
Sarah Hickman

O C E T A - Partnering for a Sustainable Future - 0 views

  •  
    OCETA accelerates the commercialization and market adoption of clean technologies and environmentally sustainable solutions. OCETA provides technical and business services to support technology entrepreneurs and start-up companies with commercializing and bringing their innovations to market. These services include: * Business mentoring and coaching: Strengthening management capability, strategic planning, route to market, IP strategy and protection. * Business networks: Connecting entrepreneurs to networks of established peers, mentors and experts. * Technology: Providing 3rd party assessment, demonstration, verification, scale-up and deployment. * Financing: Finding access to capital and improving investment readiness. * Marketing: Assisting in market niche identification and segmentation and export assistance.
Cathy Bogaart

2010: Marketing is not Marketing | - 1 views

  • Don’t just email them one-way marketing spam featuring the next product you want them to purchase.
  • You need to build an entire support ecosystem that allows you to channel conversations to the right place.
  • If you believe in your brand, your workplace, and your employees then you have nothing to hide. If you do have something to hide, fix it, because no amount of marketing will.
  • ...3 more annotations...
  • They are a visionary; they’re always the smartest person in the room, and they drop gorgeous nuggets of wisdom without even realizing it. Elevate them! They should be blogging and Tweeting daily.
  • But don’t make them just shill for the brand.
  • Give the lowest member of the customer support team a vehicle to share his ideas with the product development team.
  •  
    Brett Virmalo of Foward Thinking writes a great must-read about what the "new marketing" really is: your customers and your employees and really great products. Stop marketing. Start being genuinely good. It's the "new" secret sauce.
Sarah Hickman

U.S. Commercial Service : Your Global Business Partner - 0 views

  •  
    The US Commercial Service provides an excellent and free-for-use International Market Research search tool for 18 global industries. Global market research reports, country commercial guides, and best market reports can be accessed via search by industry, sector, region, country, keyword, or type of report. Older archived records can also be retrieved. The site offers search tips for finding market reports, as well as e-alerts.
Sarah Hickman

Amazon.com: In Search of the Obvious: The Antidote for Today's Marketing Mess (97804702... - 0 views

  •  
    Advertisers are criticized as people who look for the creative and edgy, not the obvious. They will not be happy.Marketing people are criticized for getting hopelessly entangled in corporate egos and complicated projects. They will not be happy.Research people are criticized for generating more confusion than clarity. They will not be happy. Some big companies are criticized for their ill-fated marketing programs or lack of proper strategy. They will not be happy.Wall Street is criticized for putting too much emphasis on growth that is unnecessary and can be destructive to a brand. They will just ignore this criticism and continue trying to make as much money as they can. But this is a book not written to make people happy but to explain to marketers what their real problem is. Only then will they begin to look for the obvious solutions that will separate their products from their competitors -- in a way that is equally obvious to customers. All this comes with no jargon, no numbers, no complexity, and a great deal of common sense.
Sarah Hickman

The Well-Designed Global R&D Network - 0 views

  •  
    Consider the two faces of the global innovation movement. Company A, having grown through acquisition, produces multiple brands for multiple markets and operates a worldwide network of research and product development centers. Each of its R&D sites was initially responsible for its own brands and local market, but with globalization these distinctions have lost their importance. Company B, on the other hand, was built largely through internal growth and has two global brands. It operates one primary R&D center supported by a handful of special-purpose sites around the world. This comparatively sparse network has helped Company B win wide admiration for the efficiency of its engineering. Because expanding the number of nodes in a network exponentially increases its complexity, it is not surprising that Company A's R&D structure is more expensive to operate. Company A has considered closing some sites, but has resisted doing so because it fears losing capabilities and insights, and roiling local markets. Meanwhile, incremental budget cuts have chipped away at engineer and supplier morale. Having built its network to maximize the value associated with market access, it is now forced to manage the network for cost. Most global innovation networks look like Company A's - and suffer the same problems. Company B's R&D structure is clearly more productive, but it is not necessarily ideal either. Its network might be too compact, limiting access to knowledge that could maximize performance. Thus, to identify principles and practices for creating a truly well-designed innovation network, Booz Allen Hamilton and INSEAD, the international business school, surveyed R&D leaders in 186 companies from 17 industry sectors in 19 nations in 2005. The survey results, and our own experience, suggest one central truth: Organizations benefit when they configure their innovation networks for cost and manage them for value.
Sarah Hickman

IDC Research - Home - 0 views

  •  
    IDC is a global provider of market intelligence, advisory services, and events for the information technology, telecommunications, and consumer technology markets. Technology advice can be searched by industry (energy, financial, health, life sciences, manufacturing, and other), or by country/region. The Canadian site provides geographical, business, communications, consumer, web, health, manufacturing, financial and other market reports. For the full list go here. The site also requires a subscription (free) to access most full-text documents - some reports may still require payment.
Sarah Hickman

Amazon.com: Crossing the Chasm: Marketing and Selling Disruptive Products to Mainstream... - 0 views

  •  
    A marketing book by Geoffrey A. Moore that focuses on the specifics of marketing high tech products. Moore's exploration and expansion of the diffusions of innovations model has had a significant and lasting impact on high tech entrepreneurship.
Assunta Krehl

Market Morning : July 3, 2009 : Market Lookahead [07-03-09 9:15 AM] - 0 views

  •  
    Interview with Dr. Rafael Hofstein about how MaRS Innovation will help to accelerate the pace in turning ideas into meaningful products which in turns help the healthcare system. Dr. Hofstein also talked about the 2 medical products that were brought to market: i) Umbilical Cord Stem Cell Technology ii) Diabetic Wound Healing Technology."
Assunta Krehl

Competing designs for market-courthouse unveiled - The Star - May 7, 2010 - 0 views

  •  
    Five architects' have been chosen as finalists in the competition to replace the bland St. Lawrence north market with a combined market and courtroom complex. Adamson Associates, who designed the MaRS building, is one of the five respected firms.
Cathy Bogaart

Marketing your Small Business Brand, Venture Accelerator Partners, Feb 24, 2011 - 0 views

  •  
    Venture Accelerator Partners recap and summarize the Entrepreneurship 101 lecture on Marketing with guest lecturer, Mark Evans.
Sarah Hickman

Thomson Financial - Canada's Venture Industry Experts - 0 views

  •  
    A product of Thomson, VCReporter gives access to market intelligence. One can, for example, access profiles of venture-backed companies and analyze trends by sector, geography, and fund manager. VCReporter also provides market news feeds, statistics, free reports and presentations, and a glossary of business terms.
  •  
    A product of Thomson, VCReporter gives access to market intelligence. One can, for example, access profiles of venture-backed companies and analyze trends by sector, geography, and fund manager. VCReporter also provides market news feeds, statistics, free reports and presentations, and a glossary of business terms.
Assunta Krehl

The Social Consumer: Cashing in on the social graph - MaRS Market Insights - Toronto - ... - 0 views

  •  
    MaRS is having a Market Insights event on social commerce opportunities on April 17.
Sarah Hickman

Amazon.com: Hidden in Plain Sight: How to Find and Execute Your Company's Next Big Grow... - 0 views

  •  
    From Booklist: Joachimsthaler offers another book that promotes use of reinvented basic marketing principles to assist highly innovative companies. The author describes his DIG model (Demand-First Innovation & Growth), which consists of three interlinked parts: explore the demand for their products and services through an in-depth understanding of how people behave and live their lives and how they consume; apply an innovative routine of structured thinking to identify opportunities that customers cannot articulate; and formulate a strategy for effectively pursuing new opportunities. We learn that although most companies conduct some type of market research, they may fail to look for real opportunities and quantify them or fail to develop viable action plans that lead to results. This model illustrates how to become an unbiased observer of people's consumption and usage behaviors and offers a new approach to identifying and executing a company's growth strategy. Joachimsthaler, a consultant, reports that "successful opportunities for innovation and growth are right here, in front of us, and we often can't see them or don't act on them." Mary Whaley Copyright © American Library Association. All rights reserved
Assunta Krehl

Pharmafocus.com - 0 views

  • Canada has always had to fight hard to attract talent and investment
  • MaRS Vital to Toronto's life sciences vision is MaRS (derived from Medical and Related Sciences) a non-profit organisation and business centre located in the heart of the city. Its core function is as a biotech incubator and business park, known as MaRS Discovery District. The venture was first established in 2000 to help foster and accelerate the growth of successful Canadian businesses and, after some uncertain times, it is now gathering momentum. A separate technology transfer office, MaRS Innovation, has also been established that, it is hoped, can be a world beater in its own right (see Turning good ideas into world beaters below). The location of the MaRS building in central Toronto is important, as it is just a stone's throw away from an existing cluster of universities and academic hospitals. MaRS has many links with other research-based organisations, including collaborations with three local universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS occupies the Old Toronto general hospital, where insulin was first discovered by Best and Banting in 1921 and then developed for use in human trials. The 21st Century organisation can build on this heritage in patient-focused discovery and development. Formerly the head of venture capital firm Primaxis, Ilse Treurnicht is chief executive of MaRS Discovery District. She acknowledges the crisis in venture capital funding, and says Canada's sector has always had less access funds through this route than other countries. This is one of the drivers behind the search for a new approach. Treurnicht says the old models of building biotech and life sciences businesses have to be discarded, as they have failed to build companies with critical mass. She says MaRS' new 'Convergence Innovation' strategy of bringing science, capital and business together will pay off.
  • "We call our strategy 'Convergence Innovation' and what we are trying to do is move away from the old linear model of academics struggling in their spare time to build companies or entrepreneurs doing this in a very incremental way."It takes time and it has many risk points along the way. So using this Convergence centre model to create a much more dynamic organisation which can help accelerate good ideas towards the commercialisation." But she says Canada's geography and demographics are always going to be a challenge. "This is a very large country with a small population. If you think in terms of clusters and hub regions, Canada's business hubs are separated geographically, and there is not much in between in terms of people."That means we can't try to be a little United States, because we just won't show up on the radar. We have to take a different approach. We have to think about collaboration as our potential competitive advantage - that means using networks and associations to solve problems and build businesses."So as new opportunities emerge, we can take them to market faster and hopefully with a higher success rate." The centre currently accommodates numerous start up companies, as well as those providing legal and financial services to them. AstraZeneca and GlaxoSmithKline also have offices on site. In all, MaRS provides mentoring for over 200 different companies across Ontario, and runs courses on entrepreneurship and preparing products for market.
  • ...7 more annotations...
  • Transition Therapeutics is one of the companies based at MaRS, and is an example of a biopharmaceutical company that is taking a new approach to the science and business of drug development.
  • Now Toronto's MaRS Innovation (MI) has been launched to try to guide and accelerate these promising ideas out of the wilderness and onto the market. MI is a not-for-profit technology transfer company that will channel all the best ideas to come out of Toronto's renowned academic centres. In the Toronto and Ontario area there were between 14-16 different technology transfer offices in the different institutions, and MaRS Innovation resolved to bring these interests together into a single entity after industry partners told them it was an inefficient way to do business. Bringing together the different institutions under one umbrella organisation has been an arduous task for MaRS, but the reward could be considerable for all parties. MI now oversees probably the largest intellectual property pipeline of its kind, representing about $1 billion in annual research spending. This means MI will be a unified route for all of Toronto's academics and their institutions when they want to develop and commercialise a bright idea. Most importantly, investors from industry who are looking to collaborate will now be able to deal with just organisation and one IP process. MI will cover patentable ideas across a broad range of areas, and not just life sciences - the discovery pipeline in physical sciences, information and communication technology, and green technology ('cleantech') will all be funnelled through MI. MI now represents three universities, 10 academic teaching hospitals and the Ontario Institute for Cancer Research. MaRS Innovation, with support from MaRS and BioDiscovery Toronto, will advance commercialisation through industry partnerships, licensing and company creation.
  • ts chief executive is Dr Rafi Hofstein. Hofstein has been headhunted from Israel where he was chief executive of Hadasit, the technology transfer company of the Hadassah Medical Organization in Jerusalem and chair of the publicly-traded company Hadasit BioHolding. He brings this considerable experience in technology transfer to what he thinks is a groundbreaking enterprise."MaRS Innovation is a unique global initiative, and I must commend the institutional leaders in Toronto for pulling this innovation powerhouse together to strengthen commercialisation output." He adds: "I believe this is going to modernise the whole notion of tech transfer." He says the scale and diversity of MaRS Innovation's remit puts it into a league of its own. Other research clusters elsewhere in the world have attempted similar projects before, but have been thwarted by the difficulty in bringing parties together. MaRS Innovation will also help launch and grow new spin-off companies and incubate them for 2-3 years to ensure a strong commercial footing. Hofstein says MI will also fund proof of concept trials which will persuade major pharma companies to invest in their development.
  • MI has just announced its first two commercialisation deals with academic partners in the city. The first is with the Samuel Lunenfeld Research Institute of Mount Sinai Hospital to develop stem cell from umbilical cords to treat cardiovascular disease, diabetes and neurological disorders. "With the Toronto area identified as a world-leading cluster in stem cell research, we are extremely excited to have identified this technology as our first commercialisation opportunity," said Dr Hofstein.
  • "Our partnership with MaRS Innovation on developing methods for using stem cells for diseases such as diabetes will allow us to work towards advancing care for these critical conditions."
  • The second collaboration is between MI and The University of Toronto (U of T) and involves a novel sustained release formulation of nitric oxide (NO) for applications in wound healing, including diabetic ulcers. "There are 300 million diabetics worldwide, of which some 15% develop troublesome foot ulcers. This wound healing technology is extremely exciting, making it an early commercialisation opportunity that MaRS Innovation has identified as being a potential win for some 45 million diabetics globally," said Dr Hofstein.
  • "This is one of many new commercialisation ventures that will be initiated by MaRS Innovation, our partner in commercialisation of research with 13 other academic institutions across the Greater Toronto Area," said Paul Young, U of T's vice-president, Research. "We at U of T are delighted that this innovation from Dr Lee will be taken to the marketplace to the benefit of society and the economy of Ontario and Canada." By aggregating the leading edge science of its institutional members and being a one-stop commercialisation centre for industry, entrepreneurs and investors, MI could really help put Toronto and Canada on the map."MaRS Innovation is deeply committed to facilitating strategic research collaborations with industry partners, strengthening the innovation capacity of Canadian industry through adoption of new technologies, and launching a new generation of robust, high-growth Canadian companies that will become global market leaders," added Dr Hofstein. "We look forward to working closely with all of our institutional members and to continue to jointly announce exciting commercial opportunities."
  •  
    Canada has always had to fight hard to attract talent and investment. As stated in Pharmafocus.com, "MaRS Discovery District helps to foster and accelerate the growth of successful Canadian businesses." MaRS Innovation has also been launched to accelerate ideas onto the market.
Assunta Krehl

reportonbusiness.com: THE COMPANY: INFONAUT INC.: Charting the right course through an ... - 0 views

  • Toronto, where a small firm is using 21st-century software to create maps with similar goals - the containment of disease - by showing infection patterns that can be understood at a glance.
  • Toronto, where a small firm is using 21st-century software to create maps with similar goals - the containment of disease - by showing infection patterns that can be understood at a glance.
  • There's nothing wrong with Infonaut using the H1N1 flu outbreak to gain exposure, as long as the company is careful in the tone it takes, said John Lute, president of Toronto communications firm Lute and Co.
  • ...15 more annotations...
  • Infonaut Inc. chief executive officer Niall Wallace and his partner, chief operating officer Matt McPherson, both former IT consultants for the Ontario government, created the company after helping to craft some of the recommendations that resulted from the SARS outbreak of 2003. They understood the value of visually represented, real-time infection data, and left government to set up Infonaut to develop that technology.
  • Infonaut has created three software products that turn infection information into maps. All are being tested in pilot projects and will soon be marketed commercially.
  • One, called Infection Watch Live, is now taking data gathered at 14 hospital emergency rooms in eastern Ontario and using it to create publicly accessible maps that show exactly where in the region cases of influenza and gastrointestinal diseases are active.
  • This complex mapping can help monitor and stop the spread of C. difficile and other superbugs.
  • The third product, called Regional Watch Live, generates maps and reports for regional health professionals by merging lab test results with a range of other information.
  • INFONAUT INC
  • Make sure to present straightforward information about how the company's products might help mitigate an outbreak in the future, but do not exaggerate promises. Be upfront about the state of pilot tests, the timelines to get the software to market, and how much funding will be needed to go to full commercialization. Use respected third-party partners to endorse the products, a move that will give the company more credibility. If there are privacy concerns, spell them out and detail how they are being addressed.
  • Infonaut should ensure that its message is understated and that the company is not an "ambulance chaser," Mr. Lute said
  • But the company does need to give straightforward information about how its products might help mitigate an outbreak in the future, and not exaggerate its promises, she said. In particular, it needs to be upfront about the state of its pilot tests and include details of when full versions of its products will be available. It also must explain how much funding they will need to get there, Ms. Wilcox said.
  • With Infonaut, there seems to be no question that there is a public gain, he said. "If it is just an opportunistic attempt to cash in on the misfortune of others, that tends to play badly. Where a company has something that can be tied to the public interest, such as in this case ... it is very low-risk."
  • He suggests that Infonaut make good use of its pilot test partners, such as the counties in eastern Ontario that are testing the Infection Watch Live system.
  • the company should forestall any concerns over privacy issues by spelling out how it ensures data on individuals are kept confidential.
  • There's nothing wrong with using the current concerns over H1N1 flu to gain exposure, as long as Infonaut is careful about taking a calm and respectful tone to its marketing and publicity.
  • On the other hand, it will clearly create an opportunity if Infonaut can increase its profile, "which helps it to get its story out, which helps it to get investors, which helps it to grow.
  • The problem Build a market for a unique infection mapping system without appearing to exploit the flu outbreak The plan: Use a subtle approach and be upfront with the state of development of the software products The payoff: Higher awareness among potential customers and an expanded market
  •  
    Using 21st-century Infonaut is using software to create maps - the containment of disease - by showing infection patterns that can be understood at a glance.
Cathy Bogaart

Milken Institute Publications - Research Reports - Capital Access Index 2008: Best Mark... - 0 views

  • infrastructures that support entrepreneurial activity by providing access to capital
  • Canada, with its stable equity market and a sound economic policy framework, was able to withstand some of the global credit market issues and moved to first place in the Milken Institute’s 2008 Capital Access Index.
  •  
    Canada ranks #1 in global access to capital index from Milken Institute, apparently thanks to our stable equity market and sound economic policy framework. That means entrepreneurs here have more support than elsewhere in the world. And we're STILL complaining about lack of start-up money? Think about how hard it must be to be everyone else.
Cathy Bogaart

Nonclinical IVDs: Growing interest in a growing field - 0 views

  • Manufacturers of human IVD technologies have been contributing their skills and knowledge more and more to the nonclinical and agricultural diagnostic markets.
  • To learn more about why IVD manufacturers are making the switch from human diagnostics and testing to agricultural and other nonclinical diagnostics, IVD Technology editor Richard Park spoke with Rocky Ganske, president and CEO of Axela Inc. (Toronto)
    • Cathy Bogaart
       
      Axela is a MaRS client.
  • Our technology allows us to work directly in a variety of sample types that are difficult for other technologies to detect pathogens in without some additional sample preparation. So that led to people who were doing BSE (mad cow)–type testing asking if we could do tests for protein directly in matrices like milk or brain homogenate, and people asking for testing in plant extracts and things like that because other technologies don’t have that capacity.
  • ...2 more annotations...
  • Axela sells to the $20-billion life sciences market with its current platform, focusing first on protein-research applications, and enabling and capturing applications for downstream personalized medicine and human diagnostics.
  • Because it’s an attractive market, you see large diagnostic companies like Bayer Animal Health move some of its testing platforms that it would use for diagnostics into animal health testing
  •  
    MaRS Client, Axela, talks about moving from human protein testing into the agricultural markets -- the challenges and the opportunities.
1 - 20 of 187 Next › Last »
Showing 20 items per page